NYSE · HCA
HCA Healthcare, Inc.
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
Loading market information…
NYSE · THC · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Tenet Healthcare Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tenet Healthcare Corporation’s forward annual dividend is $1.28 per share, paid quarterly. The forward yield is 0.47% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Tenet Healthcare Corporation’s next earnings report is currently expected on Feb 10, 2027, with estimated earnings per share of $5.58. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tenet Healthcare Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 22, 2025 | $4.02+40.07% vs estimate | $5.27B+2.14% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | $4.36+39.74% vs estimate | $5.22B+1.65% vs estimate |
|---|
| Q4 2024 | Feb 12, 2025 | $3.44+16.61% vs estimate | $5.07B-1.85% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
32 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 14 contributors · Median target $285.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
€47.00+€0.67 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 19.92% below the high.
R$32.35-R$1.34 (-3.98%)
Rede D'Or São Luiz S.A.’s quoted price sits in the lower half of its reported 52-week range, 33.17% below the high.
$176.61+$4.43 (+2.57%)
Universal Health Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.3% below the high.
A$55.73+A$0.81 (+1.47%)
Ramsay Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 0.66% below the high.
$41.25+$0.66 (+1.63%)
Concentra Group Holdings Parent, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.29% below the high.
$23.21-$0.03 (-0.13%)
Surgery Partners, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.68% below the high.
